How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,812 results for

Somatization Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Effects of cognitive-behavioral stress management training in individuals with functional somatic symptoms - an exploratory randomized controlled trial. (Abstract)

Effects of cognitive-behavioral stress management training in individuals with functional somatic symptoms - an exploratory randomized controlled trial. Stress is discussed as a risk factor in the manifestation and maintenance of functional somatic (FS) symptoms. However, there is a lack of evidence regarding the effects of cognitive-behavioral stress management training (CBSM) on FS symptoms and the (potentially mediating) role of the neuroendocrine system. This study aims to examine stress

2019 Stress (Amsterdam, Netherlands) Controlled trial quality: uncertain

2. Patient management algorithm combining processed electroencephalographic monitoring with cerebral and somatic near-infrared spectroscopy: a case series. Full Text available with Trip Pro

Patient management algorithm combining processed electroencephalographic monitoring with cerebral and somatic near-infrared spectroscopy: a case series. Cerebral oximetry is a monitoring tool used in the perioperative care of cardiac surgery patients to ensure adequate cerebral perfusion and oxygenation. When combined with somatic oximetry, the differential diagnosis of cerebral desaturation can be better identified and managed more specifically, as somatic oximetry serves as a global (...) or localized perfusion monitor (depending on its regional position). The use of processed electroencephalography (pEEG) in cardiac surgery could further guide the management of desaturation episodes, as reductions in pEEG activity without a change in the anesthetic agent level indicate potential cerebral ischemia. Continuous integration of multiple monitoring modalities are thus desirable to assess organ perfusion and organ function.Four clinical cases are presented in which the combination of pEEG

2019 Canadian Journal Of Anaesthesia

3. Cost-utility of collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: A cluster-randomized controlled trial (the SMADS trial). (Abstract)

Cost-utility of collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: A cluster-randomized controlled trial (the SMADS trial). Anxiety, depressive and somatoform disorders are highly prevalent and cause a huge economic burden. A nurse-led collaborative care intervention has been set up in order to improve self-management of patients with these mental disorders in primary care in Hamburg, Germany. The aim of this study (...) was to determine the cost-utility of this nurse-led intervention from the health care payer perspective.This analysis was part of a 12-month cluster-randomized controlled trial aiming to increase perceived self-efficacy of primary care patients with anxiety, depressive or somatic symptoms by collaborative nurse-led self-management support compared with routine care. A cost-effectiveness analysis using quality-adjusted life years was performed. Net-monetary benefit regressions adjusted for baseline differences

2018 International journal of nursing studies Controlled trial quality: uncertain

4. Real-world insights on the use of transversus abdominis plane block with liposomal bupivacaine in the multimodal management of somatic versus visceral pain in the colorectal surgery setting Full Text available with Trip Pro

Real-world insights on the use of transversus abdominis plane block with liposomal bupivacaine in the multimodal management of somatic versus visceral pain in the colorectal surgery setting 29942149 2018 11 14 1178-7090 11 2018 Journal of pain research J Pain Res Real-world insights on the use of transversus abdominis plane block with liposomal bupivacaine in the multimodal management of somatic versus visceral pain in the colorectal surgery setting. 1141-1146 10.2147/JPR.S168817 Connolly (...) Nicholas C NC Bend Anesthesiology Group, Bend, OR, USA. eng Editorial 2018 06 15 New Zealand J Pain Res 101540514 1178-7090 Disclosure Nicholas C Connolly has received consulting fees for providing advisor services to Pacira Pharmaceuticals, Inc. The author reports no other conflicts of interest in this work. 2018 6 27 6 0 2018 6 27 6 0 2018 6 27 6 1 epublish 29942149 10.2147/JPR.S168817 jpr-11-1141 PMC6007189 J Pain Palliat Care Pharmacother. 2013 Mar;27(1):62-70 23302094 J Manag Care Spec Pharm. 2014

2018 Journal of pain research

5. Management of somatic symptom disorder Full Text available with Trip Pro

Management of somatic symptom disorder This review paper gives an overview of the management of somatic symptom disorder. It starts with a description of the clinical problem of patients with persistent bodily distress, discusses classificatory, epidemiological, and etiological issues and then describes the evidence and practical principles of dealing with these patients who are often seen as "difficult" to treat. It is concluded that the best-suited approach is stepped care with close (...) cooperation of primary care, a somatic specialist, and mental health care professionals operating on the basis of a biopsychosocial model of integrating somatic as well as psychosocial determinants of distress and therapeutic factors.

2018 Dialogues in Clinical Neuroscience

6. Management of Functional Somatic Syndromes and Bodily Distress. (Abstract)

Management of Functional Somatic Syndromes and Bodily Distress. Functional somatic syndromes (FSS), like irritable bowel syndrome or fibromyalgia and other symptoms reflecting bodily distress, are common in practically all areas of medicine worldwide. Diagnostic and therapeutic approaches to these symptoms and syndromes vary substantially across and within medical specialties from biomedicine to psychiatry. Patients may become frustrated with the lack of effective treatment, doctors may (...) experience these disorders as difficult to treat, and this type of health problem forms an important component of the global burden of disease. This review intends to develop a unifying perspective on the understanding and management of FSS and bodily distress. Firstly, we present the clinical problem and review current concepts for classification. Secondly, we propose an integrated etiological model which encompasses a wide range of biopsychosocial vulnerability and triggering factors and considers

2018 Psychotherapy and Psychosomatics

7. Somatic tumour gene testing for the diagnosis of gliomas, gliobastomas, and soft tissue and bone tumours

Somatic tumour gene testing for the diagnosis of gliomas, gliobastomas, and soft tissue and bone tumours 1 Public Summary Document Application No. 1527 – somatic gene testing of central nervous system tumours and sarcomas Applicant: The Royal College of Pathologists of Australasia (RCPA) Date of MSAC consideration: MSAC 76 th Meeting, 1-2 August 2019 Context for decision: MSAC makes its advice in accordance with its Terms of Reference, visit the MSAC website 1. Purpose of application (...) abnormal growth. A somatic cell is any cell in the body that is not an egg or sperm cell, and gene mutations which 2 Consumer summary develop in - cells after the egg is fertilised are called “somatic mutations”. Somatic tumour testing is where a piece of a tumour is tested to look at the somatic mutations in the cancer cells. These tests can help provide patients with an appropriate diagnosis. Applications 1526, 1527 and 1528 are for somatic tumour testing for rare cancers. They have been grouped

2020 Medical Services Advisory Committee

8. Somatic tumour gene testing for the diagnosis of renal cell carcinoma, hydatidiform moles, granulosa cell ovarian tumour, salivary gland tumours, and secretory carcinoma of the breast

Somatic tumour gene testing for the diagnosis of renal cell carcinoma, hydatidiform moles, granulosa cell ovarian tumour, salivary gland tumours, and secretory carcinoma of the breast 1 Public Summary Document Application No. 1528 – Hydatidiform mole testing Applicant: The Royal College of Pathologists of Australasia (RCPA) Date of MSAC consideration: MSAC 77 th Meeting, 28-29 November 2019 MSAC 76 th Meeting, 1-2 August 2019 Context for decision: MSAC makes its advice in accordance with its (...) Terms of Reference, visit the MSAC website 1. Purpose of application November 2019 MSAC consideration MSAC considered the following key questions/concerns raised by the Department for somatic tumour gene testing for the assessment of hydatidiform mole: • The appropriate wording of the Medicare Benefits Schedule (MBS) item descriptor, including the proposed restrictions and the Applicant’s proposed fees for gene testing in patients with hydatidiform mole. August 2019 MSAC consideration An application

2020 Medical Services Advisory Committee

9. Somatic tumour gene testing for the diagnosis of diffuse large B cell lymphoma, multiple myeloma and non-Hodgkin lymphoma subtypes

Somatic tumour gene testing for the diagnosis of diffuse large B cell lymphoma, multiple myeloma and non-Hodgkin lymphoma subtypes 1 Public Summary Document Application No. 1526 – Somatic gene testing of haematological malignancies Applicant: The Royal College of Pathologists of Australasia (RCPA) Date of MSAC consideration: MSAC 76 th Meeting, 1-2 August 2019 Context for decision: MSAC makes its advice in accordance with its Terms of Reference, visit the MSAC website 1. Purpose of application (...) items in this application were supported. Two requested MBS items were deferred, relating to hydatidform mole (in application 1528) and analogue secretory carcinoma (in application 1528), in order to seek more information to clarify the appropriate test usage and item descriptor wording. 2 Consumer summary Cancer arises when cells develop genetic changes that cause abnormal growth. A somatic cell is any cell in the body that is not an egg or sperm cell, and gene mutations which develop in cells

2020 Medical Services Advisory Committee

10. Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report

Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report Journal Pre-proof Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report Anne B. Chang, PhD, John J. Oppenheimer, MD; FCCP, Richard S. Irwin, MD, Master FCCP, on behalf of the CHEST Expert Cough Panel PII: S0012-3692(20)30325-1 DOI: https://doi.org/10.1016/j.chest.2020.01.042 Reference: CHEST 2916 To appear in: CHEST (...) Received Date: 8 November 2019 Revised Date: 11 December 2019 Accepted Date: 9 January 2020 Please cite this article as: Chang AB, Oppenheimer JJ, Irwin RS, on behalf of the CHEST Expert Cough Panel, Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report, CHEST (2020), doi: https://doi.org/10.1016/j.chest.2020.01.042. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page

2020 American College of Chest Physicians

11. Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline | Journal of Clinical Oncology Search in: Menu Article Tools ASCO SPECIAL ARTICLES Article Tools OPTIONS & TOOLS COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.19.02960 Journal of Clinical Oncology - published online before print January 27, 2020 PMID: Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO (...) . The evidence consisted of systematic reviews of observational data, consensus guidelines, and RCTs. RECOMMENDATIONS All women diagnosed with epithelial ovarian cancer should have germline genetic testing for BRCA1/2 and other ovarian cancer susceptibility genes. In women who do not carry a germline pathogenic or likely pathogenic BRCA1/2 variant, somatic tumor testing for BRCA1/2 pathogenic or likely pathogenic variants should be performed. Women with identified germline or somatic pathogenic or likely

2020 American Society of Clinical Oncology Guidelines

12. Somatic Cancer Panel Reporting in Ontario

Somatic Cancer Panel Reporting in Ontario Sept 2019 Somatic Cancer Panel Reporting in Ontario Introduction As the use of panel testing for molecular oncology expands in Ontario clinical labs, there is an opportunity to develop a standardized approach for the generation of clear, concise reports to reduce variation in report content and format. This standardization will support clinical management decisions by providing clear summaries of genomic findings that can be easily understood by experts (...) Care Ontario’s (CCO) Pathology and Laboratory Medicine Program (PLMP). The purpose of the working group was to establish a standardized approach to: ? Variant reporting for somatic cancers ? Determine which findings and associated quality metrics should be included in a report ? Report formatting, including layout and content Need for Standardization The standardization of pathology reporting has been shown to improve the overall quality of pathology reporting and benefit clinical management

2019 Cancer Care Ontario

13. Conversion and somatic symptom disorders

psychiatric conditions benefit overall functioning and recovery. Long-term management involves interrupting perpetuating factors, maintaining the same doctor, and providing strategies for self-efficacy, distress tolerance, coping, and modulating the interaction of anxiety, stress, and physical symptoms. Definition Conversion and somatic symptom disorders are psychiatric conditions that fall under the somatic symptoms and related disorders category of the DSM-5. Somatic symptom and related disorders (...) Conversion and somatic symptom disorders Conversion and somatic symptom disorders - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Conversion and somatic symptom disorders Last reviewed: February 2019 Last updated: March 2018 Summary Conversion and somatic symptom disorders are both categorised as somatic symptom and related disorders, previously termed somatoform disorders. Somatic symptom and related disorders

2018 BMJ Best Practice

14. Two cases of somatic-type malignancy as a very late relapse of testicular cancer successfully managed by surgical resection Full Text available with Trip Pro

Two cases of somatic-type malignancy as a very late relapse of testicular cancer successfully managed by surgical resection A late-relapse germ cell tumor might contain malignant non-germ cell tumors, known as 'somatic-type malignancy (SM)'. The development of a secondary SM is rare, and this phenomenon remains poorly understood. Case 1 developed lung metastasis 13 years after chemotherapy followed by retroperitoneal lymph node dissection for stage IIA non-seminoma. The tumor increased in size

2017 Journal of surgical case reports

15. Olaparib (Lynparza) - advanced (FIGO stages III and IV) BRCA1/2-mutated (germline and/or somatic) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer

Olaparib (Lynparza) - advanced (FIGO stages III and IV) BRCA1/2-mutated (germline and/or somatic) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer Published 09 December 2019 1 SMC2209 olaparib 100mg and 150mg film-coated tablets (Lynparza®) AstraZeneca UK Limited. 8 November 2019 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) on its use in NHSScotland (...) . The advice is summarised as follows: ADVICE: following a full submission considered under the orphan equivalent process olaparib (Lynparza ® ) is accepted for use within NHSScotland. Indication under review: for the maintenance treatment of adult patients with advanced (FIGO stages III and IV) BRCA1/2-mutated (germline and/or somatic) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based

2019 Scottish Medicines Consortium

16. Guidelines for diagnosing and managing pediatric concussion

Guidelines for diagnosing and managing pediatric concussion Guidelines for Diagnosing and Managing Pediatric Concussion First edition, June 2014, v1.1 Recommendations for Health Care Professionals This document is intended to guide health care professionals in diagnosing and managing pediatric—not adult—concussion. It is not for self-diagnosis or treatment. Parents and/or caregivers may bring it to the attention of their child/adolescent’s health care professionals. The best knowledge available (...) or damage arising from any claims made by a third party. Also, as the sponsor of this document, the Ontario Neurotrauma Foundation assumes no responsibility or liability whatsoever for changes made to the guidelines without its consent. Any changes must be accompanied by the statement: “Adapted from Guidelines for Diagnosing and Managing Pediatric Concussion with/without permission,” according to whether or not permission was sought and/or given. About the Ontario Neurotrauma Foundation The Ontario

2019 CPG Infobase

17. Guidance on the clinical management of anxiety disorders, specifically focusing on diagnosis and treatment strategies

Guidance on the clinical management of anxiety disorders, specifically focusing on diagnosis and treatment strategies Objective: To provide practical clinical guidance for the treatment of adults with panic disorder, social anxiety disorder and generalised anxiety disorder in Australia and New Zealand. Method: Relevant systematic reviews and meta-analyses of clinical trials were identified by searching PsycINFO, Med- line, Embase and Cochrane databases. Additional relevant studies were (...) Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treat- ment of panic disorder, social anxiety disorder and generalised anxiety disorder provide up-to-date guidance and advice on the management of these disorders for use by health professionals in Australia and New Zealand. Keywords Guidelines, panic disorder, agoraphobia, social anxiety disorder, generalised anxiety disorder, management, treatment Executive summary Anxiety is normal Anxiety can be good for us

2018 Royal Australian and New Zealand College of Psychiatrists

18. Somatization Management

Somatization Management Somatization Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Somatization Management Somatization (...) Management Aka: Somatization Management , Somatoform Disorder Management , Somatic Symptom Disorder Management From Related Chapters II. Management: Strategies to avoid See Do not suggest "it's all in your head" Do not order endless testing without indications Avoid unnecessary invasive tests or medications Avoid over referring to specialists Do not focus on symptoms (focus on function instead) III. Management: Protocol Assign a single designated physician Establish long-term empathetic relationship

2018 FP Notebook

19. Management of Dyslipidaemias Full Text available with Trip Pro

Management of Dyslipidaemias 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close (...) mobile search navigation Article Navigation Article Contents Article Navigation 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk : The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) François Mach Chairperson Switzerland Corresponding authors: François Mach, Cardiology Department, Geneva University Hospital, 4 Gabrielle-Perret-Gentil, 1211 Geneva

2019 European Society of Cardiology

20. Management of Hereditary Breast Cancer

Management of Hereditary Breast Cancer Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline | Journal of Clinical Oncology Search in: Menu > > > > Article Tools ASCO SPECIAL ARTICLES Article Tools OPTIONS & TOOLS COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.20.00299 Journal of Clinical Oncology - published online before print April 3, 2020 PMID: Management (...) Beaumont Health, Royal Oak, MI N.M.T. and D.Z. were Expert Panel co-chairs. Abstract Section: PURPOSE To develop recommendations for management of patients with breast cancer (BC) with germline mutations in BC susceptibility genes. METHODS The American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology convened an Expert Panel to develop recommendations based on a systematic review of the literature and a formal consensus process. RESULTS Fifty-eight

2020 American Society of Clinical Oncology Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>